Kangmei Pharma | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
Alaunos Therapeutics -1127000 1.11M 2024-09
Avita Medical AUD 16.13M 3.05M 2024-12
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Genomma Lab Internacional MXN 2.94B 330.33M 2024-12
Hypermarcas BRL 786.44M 359.27M 2024-12
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Jiangsu Hengrui CNY 5.57B 1.04B 2024-09
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Moderna USD 420M 1.14B 2024-12
Organon & Co USD 896M 27M 2024-12
Revvity USD 412.29M 27.47M 2024-12
Sh Fosun Pharma CNY 4.6B 354.14M 2024-12
Viatris USD 1.39B 211M 2024-12
Wuxi Apptec CNY 5.02B 612.31M 2024-12
Xeris Pharmaceuticals USD 50.62M 9.95M 2024-12
Zz Pientze Pharmaceu 1.29B 268M 2024-09



Kangmei Pharma Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.